FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229366952> ?p ?o ?g. }

• W4229366952 endingPage "551" @default.
• W4229366952 startingPage "551" @default.
• W4229366952 abstract "There is an urgent need for an oral drug for the treatment of mild to moderate outpatient SARS-CoV-2. Our preclinical and clinical study’s aim was to determine the safety and preliminary efficacy of oral TQ Formula (TQF), in the treatment of outpatient SARS-CoV-2. In a double-blind, placebo-controlled phase 2 trial, we randomly assigned (1:1 ratio) non-hospitalized, adult (>18 years), symptomatic SARS-CoV-2 patients to receive oral TQF or placebo. The primary endpoints were safety and the median time-to-sustained-clinical-response (SCR). SCR was 6 days in the TQF arm vs. 8 days in the placebo arm (p = 0.77), and 5 days in the TQF arm vs. 7.5 days in the placebo arm in the high-risk cohort, HR 1.55 (95% CI: 0.70, 3.43, p = 0.25). No significant difference was found in the rate of AEs (p = 0.16). TQF led to a significantly faster decline in the total symptom burden (TSB) (p < 0.001), and a significant increase in cytotoxic CD8+ (p = 0.042) and helper CD4+ (p = 0.042) central memory T lymphocytes. TQF exhibited an in vitro inhibitory effect on the entry of five SARS-CoV-2 variants. TQF was well-tolerated. While the median time-to-SCR did not reach statistical significance; it was shorter in the TQF arm and preclinical/clinical signals of TQF activity across multiple endpoints were significant. Therefore, a confirmatory study is planned." @default.
• W4229366952 created "2022-05-10" @default.
• W4229366952 creator A5000735375 @default.
• W4229366952 creator A5007769285 @default.
• W4229366952 creator A5009594882 @default.
• W4229366952 creator A5016812694 @default.
• W4229366952 creator A5030988275 @default.
• W4229366952 creator A5031032689 @default.
• W4229366952 creator A5038851564 @default.
• W4229366952 creator A5046065062 @default.
• W4229366952 creator A5047311893 @default.
• W4229366952 creator A5057966417 @default.
• W4229366952 creator A5057981513 @default.
• W4229366952 creator A5061608884 @default.
• W4229366952 creator A5064510716 @default.
• W4229366952 creator A5066030162 @default.
• W4229366952 creator A5066556992 @default.
• W4229366952 creator A5066804278 @default.
• W4229366952 creator A5072278307 @default.
• W4229366952 creator A5072656760 @default.
• W4229366952 creator A5072678771 @default.
• W4229366952 creator A5074184830 @default.
• W4229366952 creator A5077290507 @default.
• W4229366952 creator A5081370837 @default.
• W4229366952 creator A5083530396 @default.
• W4229366952 creator A5089217408 @default.
• W4229366952 creator A5089687882 @default.
• W4229366952 date "2022-05-07" @default.
• W4229366952 modified "2023-10-16" @default.
• W4229366952 title "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2" @default.
• W4229366952 cites W1553907965 @default.
• W4229366952 cites W1982181755 @default.
• W4229366952 cites W2058890808 @default.
• W4229366952 cites W2148685950 @default.
• W4229366952 cites W2154345920 @default.
• W4229366952 cites W3013776441 @default.
• W4229366952 cites W3013992432 @default.
• W4229366952 cites W3017286817 @default.
• W4229366952 cites W3019773443 @default.
• W4229366952 cites W3020184843 @default.
• W4229366952 cites W3022531685 @default.
• W4229366952 cites W3023982717 @default.
• W4229366952 cites W3036101703 @default.
• W4229366952 cites W3036671059 @default.
• W4229366952 cites W3044231852 @default.
• W4229366952 cites W3137683991 @default.
• W4229366952 cites W3158808824 @default.
• W4229366952 cites W3160121817 @default.
• W4229366952 cites W3161424923 @default.
• W4229366952 cites W3162323711 @default.
• W4229366952 cites W3170609530 @default.
• W4229366952 cites W3193494785 @default.
• W4229366952 cites W3207243906 @default.
• W4229366952 cites W81657705 @default.
• W4229366952 doi "https://doi.org/10.3390/pathogens11050551" @default.
• W4229366952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35631072" @default.
• W4229366952 hasPublicationYear "2022" @default.
• W4229366952 type Work @default.
• W4229366952 citedByCount "4" @default.
• W4229366952 countsByYear W42293669522022 @default.
• W4229366952 countsByYear W42293669522023 @default.
• W4229366952 crossrefType "journal-article" @default.
• W4229366952 hasAuthorship W4229366952A5000735375 @default.
• W4229366952 hasAuthorship W4229366952A5007769285 @default.
• W4229366952 hasAuthorship W4229366952A5009594882 @default.
• W4229366952 hasAuthorship W4229366952A5016812694 @default.
• W4229366952 hasAuthorship W4229366952A5030988275 @default.
• W4229366952 hasAuthorship W4229366952A5031032689 @default.
• W4229366952 hasAuthorship W4229366952A5038851564 @default.
• W4229366952 hasAuthorship W4229366952A5046065062 @default.
• W4229366952 hasAuthorship W4229366952A5047311893 @default.
• W4229366952 hasAuthorship W4229366952A5057966417 @default.
• W4229366952 hasAuthorship W4229366952A5057981513 @default.
• W4229366952 hasAuthorship W4229366952A5061608884 @default.
• W4229366952 hasAuthorship W4229366952A5064510716 @default.
• W4229366952 hasAuthorship W4229366952A5066030162 @default.
• W4229366952 hasAuthorship W4229366952A5066556992 @default.
• W4229366952 hasAuthorship W4229366952A5066804278 @default.
• W4229366952 hasAuthorship W4229366952A5072278307 @default.
• W4229366952 hasAuthorship W4229366952A5072656760 @default.
• W4229366952 hasAuthorship W4229366952A5072678771 @default.
• W4229366952 hasAuthorship W4229366952A5074184830 @default.
• W4229366952 hasAuthorship W4229366952A5077290507 @default.
• W4229366952 hasAuthorship W4229366952A5081370837 @default.
• W4229366952 hasAuthorship W4229366952A5083530396 @default.
• W4229366952 hasAuthorship W4229366952A5089217408 @default.
• W4229366952 hasAuthorship W4229366952A5089687882 @default.
• W4229366952 hasBestOaLocation W42293669521 @default.
• W4229366952 hasConcept C126322002 @default.
• W4229366952 hasConcept C141341695 @default.
• W4229366952 hasConcept C142724271 @default.
• W4229366952 hasConcept C197934379 @default.
• W4229366952 hasConcept C203092338 @default.
• W4229366952 hasConcept C204787440 @default.
• W4229366952 hasConcept C27081682 @default.
• W4229366952 hasConcept C3020110884 @default.
• W4229366952 hasConcept C535046627 @default.
• W4229366952 hasConcept C65409693 @default.

• next